Exe Brochure Zaffiro 28022024 WEB - Flipbook - Page 9
1
FILLERS
Neauvia PEG-HA Fillers are based on a unique Smart
Crosslinkig Technology - SXT - combining HA and PEG.
This gives outstanding mechanical, rheological and
thermodynamic properties to the Neauvia’s portfolio,
ensuring a high safety profile and tolerability. Thanks to these
unique properties, they can be perfectly associated with
Neauvia Energy-Based Devices and Neauvia Aesthetic
Cosmeceuticals, resulting in improved clinical results through
synergistic effects and enhanced aesthetic outcomes.1,2,3
2
DEVICES
Neauvia provides a range of energy-based
devices for the aesthetic, gynecological
and surgical markets. Neauvia Energy-Based
Devices are characterized by advanced
electromedical engineering. They are based
on specifically designed and integrated
technology, allowing optimal results in
combination with Neauvia PEG-HA Fillers
and cosmeceuticals, ensuring maximum
patient safety.1,2,3
3
AESTHETIC
COSMECEUTICALS
Based on advanced knowledge and research on active
ingredients, Neauvia Aesthetic Cosmeceuticals offer
a professional and exclusive skincare range.
High quality and scientifically based, they are suitable
for skin preparation, post-treatment and home care,
designed to work in synergy with aesthetic treatments.
1. Kubik P, Jankau J, Rauso R, Galadari H, Protasoni M, Gruszczyński W, Grzanka D, Smolińska M, Antosik P, Piesiaków ML, Zerbinati N et al. HA PEGylated filler in
association with an infrared energy device for the treatment of facial skin aging: 150 day follow-up data report. Pharmaceuticals 2022, 15, 1355. https://doi.
org/10.3390/ph15111355
2. Kolczewski P, Parafiniuk M, Zawodny P, Haddad R, Nalewczyńska A, Kolasa AK, Wiszniewska B, Menkes S, Bader A, Stabile G and Zerbinati N. Hyaluronic Acid
and radiofrequency in patients with urogenital atrophy and vaginal laxity. Pharmaceuticals 2022, 15, 1571. https://doi.org/10.3390/ph15121571
3. Płatkowska A, Korzekwa S, Łukasik B and Zerbinati N. combined bipolar radiofrequency and non-crosslinked Hyaluronic Acid mesotherapy protocol to
improve skin appearance and epidermal barrier function: a pilot study. Pharmaceuticals 2023, 16, 1145. https://doi.org/10.3390/ph16081145